Tanvex BioPharma, Inc. (6541.TW)

TWD 64.1

(7.19%)

Eps Summary of Tanvex BioPharma, Inc.

Tanvex BioPharma, Inc.'s latest annual eps in 2023 was -16.42 TWD , down -21.18% from previous year.
Tanvex BioPharma, Inc.'s latest quarterly eps in 2024 Q1 was -3.12 TWD , up 18.54% from previous quarter.
Tanvex BioPharma, Inc. reported an annual eps of -13.55 TWD in 2022, up 1.81% from previous year.
Tanvex BioPharma, Inc. reported an annual eps of -13.80 TWD in 2021, up 38.97% from previous year.
Tanvex BioPharma, Inc. reported a quarterly eps of -3.12 TWD for 2024 Q1, up 18.54% from previous quarter.
Tanvex BioPharma, Inc. reported a quarterly eps of -3.83 TWD for 2023 Q4, down -2.41% from previous quarter.

Annual Eps Chart of Tanvex BioPharma, Inc. (2023 - 2013)

Historical Annual Eps of Tanvex BioPharma, Inc. (2023 - 2013)

Year	Eps	Eps Growth
2023	-16.42 TWD	-21.18%
2022	-13.55 TWD	1.81%
2021	-13.80 TWD	38.97%
2020	-22.61 TWD	13.57%
2019	-26.16 TWD	-4.89%
2018	-24.94 TWD	-20.72%
2017	-20.66 TWD	-11.37%
2016	-18.55 TWD	-10.94%
2015	-16.72 TWD	-23.12%
2014	-13.58 TWD	-36.62%
2013	-9.94 TWD	0.0%

Year	Eps	Eps Growth
2024 Q2	-2.31 TWD	25.96%
2024 Q1	-3.12 TWD	18.54%
2023 Q4	-3.83 TWD	-2.41%
2023 Q2	-3.85 TWD	26.39%
2023 FY	- TWD	-21.18%
2023 Q3	-3.74 TWD	2.86%
2023 Q1	-5.23 TWD	-28.82%
2022 Q2	-3.63 TWD	-23.47%
2022 Q4	-4.06 TWD	-14.04%
2022 Q3	-3.56 TWD	1.93%
2022 Q1	-2.94 TWD	-196.97%
2022 FY	- TWD	1.81%
2021 Q4	-0.99 TWD	72.5%
2021 FY	- TWD	38.97%
2021 Q2	-3.64 TWD	8.77%
2021 Q1	-3.99 TWD	-131.98%
2021 Q3	-3.60 TWD	1.1%
2020 Q4	-1.72 TWD	66.73%
2020 Q1	-7.00 TWD	-230.19%
2020 Q2	-6.37 TWD	9.0%
2020 Q3	-5.17 TWD	18.84%
2020 FY	- TWD	13.57%
2019 Q4	-2.12 TWD	74.94%
2019 Q1	-6.36 TWD	-243.78%
2019 FY	- TWD	-4.89%
2019 Q2	-6.22 TWD	2.2%
2019 Q3	-8.46 TWD	-36.01%
2018 Q3	-5.75 TWD	31.22%
2018 FY	- TWD	-20.72%
2018 Q2	-8.36 TWD	-94.42%
2018 Q1	-4.30 TWD	-115.0%
2018 Q4	-1.85 TWD	67.83%
2017 Q1	-5.09 TWD	-120.35%
2017 Q2	-5.05 TWD	0.79%
2017 FY	- TWD	-11.37%
2017 Q3	-4.48 TWD	11.29%
2017 Q4	-2.00 TWD	55.36%
2016 FY	- TWD	-10.94%
2016 Q2	-4.66 TWD	-81.32%
2016 Q3	-4.35 TWD	6.65%
2016 Q4	-2.31 TWD	46.9%
2016 Q1	-2.57 TWD	67.67%
2015 Q2	-3.37 TWD	0.0%
2015 Q4	-7.95 TWD	-76.67%
2015 Q3	-4.50 TWD	-33.53%
2015 Q1	-3.37 TWD	-274.44%
2015 FY	- TWD	-23.12%
2014 Q4	-0.90 TWD	0.0%
2014 Q2	-3.78 TWD	0.0%
2014 Q1	-3.78 TWD	0.0%
2014 FY	- TWD	-36.62%
2014 Q3	-0.90 TWD	76.19%
2013 FY	- TWD	0.0%

Peer Eps Comparison of Tanvex BioPharma, Inc.

Name	Eps	Eps Difference
Apex Biotechnology Corp.	1.16 TWD	1515.517%
Sinphar Pharmaceutical Co.,Ltd.	2.24 TWD	833.036%
Panion & Bf Biotech Inc.	0.90 TWD	1924.444%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	3.42 TWD	580.117%
GenMont Biotech Incorporation	0.38 TWD	4421.053%
Abnova (Taiwan) Corporation	0.72 TWD	2380.556%
Adimmune Corporation	-1.52 TWD	-980.263%
Polaris Group	-2.12 TWD	-674.528%
Energenesis Biomedical CO.,LTD.	-3.62 TWD	-353.591%
UnicoCell Biomed Co., Ltd.	-1.56 TWD	-952.564%
PELL Bio-Med Technology Co. Ltd.	-8.62 TWD	-90.487%